May 21, 2020
HKBU invents nanostructure that stimulates growth of stem cells for Parkinson's disease treatment
Apr 03, 2020
Axon Presented Positive Phase II Trial Results of AADvac1 at AAT-AD/PD 2020
Apr 01, 2020
Aspen Neuroscience Announces $70 Million Series A Financing Led by OrbiMed to Advance Development of the First Autologous Neuron Replacement Therapy to Treat Parkinson Disease
Feb 25, 2020
Bit Bio Secures Distribution Agreement with Abcam to Democratize Access to Human Cells for Global Life Science Research
Feb 11, 2020
US Nuclear Joins the Brain-Machine Interface Revolution
Dec 20, 2019
GB Sciences Announces Outstanding Results from Preclinical Study of Its Parkinson's Disease Formulations
Dec 10, 2019
Neuron EV Opens Exhibition in Hollywood and Shanghai
Dec 06, 2019
Neuron EV Introduces Pure Electric TORQ
Dec 03, 2019
Clene Nanomedicine Announces First Patient Enrolled in the REPAIR-PD Clinical Trial for the Treatment of Parkinson's Disease with the Nanocatalytic Therapeutic, CNM-Au8
Nov 22, 2019
Global Central Nervous System Deal Trends, Players and Financials Partnering 2014-2019
Nov 22, 2019
Neuron EV Releases Stunning T-ONE Image Gallery with Q&A
Nov 06, 2019
Neuron Upgrades the Future of EV at CIIE
Oct 14, 2019
Allen Institute Debuts New Window Into Brain Cell Communication
Oct 01, 2019
Neuron EV Launches Modular Electric Trucks
Sep 09, 2019
Axon Announces Positive Results From Phase II ADAMANT Trial for AADvac1 in Alzheimer's Disease
Aug 16, 2019
Pinpointing How Cells Regulate Long-Lasting Memories
Aug 01, 2019
Neuron ESB named Summer 2019 "High Performer" by G2 Crowd
Jul 17, 2019
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38a Kinase Inhibitor Neflamapimod on the Neurodegenerative Process
Jul 08, 2019
Neuron EV Unveils the Future of Smart Travel and Residence
Jun 23, 2019
Kanazawa University Research: Structural Development of the Brain